Teresa Dahlman

Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001.

Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.

Jwm Pharmaceutical Services, Inc. prepares and distributes pharmaceutical products. The private company is based in San Bruno.

TechnoDerma Medicines, Inc. is a company based in Jiaxing, China. TechnoDerma Medicines, Inc. is a learning center for commercial operation managed by Shanghai Energy Enterprise Management Consulting Co., Ltd. The Chinese company aggregates professionals through alliances and alliances to build a tribal operating model by project. TechnoDerma Medicines, Inc. offers a range of services, including product management, business analysis, agile lean operation and maintenance devops, professional skills transformation, certified practical public training, and corporate customized internal training and consultation. The company was founded in 2014 by Zeng Quan Wang, who has been the CEO since 2014.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada.